Dr. John Wade, MD, FRCP(C), talks about the various treatment options for Rheumatoid Arthritis including revolutionary second line therapies. Fact check: Trump makes numerous false claims to generals ...

Rosnilimab, a selective depleter of pathogenic T cells, is a potential game changer for the treatment of moderate-to-severe rheumatoid arthritis (RA). In a new Phase 2b clinical trial, rosnilimab ...

Interleukin (IL)-1 is a prototypic proinflammatory cytokine. It is produced by numerous cell types (i.e., macrophages, synoviocytes, endothelial cells, chondrocytes, osteoclasts) and is found in ...

RA can affect your lifespan in various ways related to cardiovascular disease, lung disease, infection, depression, and ...

Cedars-Sinai’s center provides personalized, multidisciplinary care for RA and related conditions, improving patient outcomes and quality of life. Dr. Jon Giles' research explores autoimmune disease ...

Non-steroidal anti-inflammatory drugs (NSAIDs) and steroids (see Corticosteroid Therapy) can be useful for acute pain relief in patients with rheumatoid arthritis (RA). In osteoarthritis, studies have ...

Rheumatoid arthritis, also known as RA, affects an estimated 1.3 million people in the United States. Beyond this staggering statistic lies a complex reality: each person's experience with RA is ...

Functional MRI studies have established that subjective feelings of pain and fatigue have objective correlates in terms of neuronal activity patterns. This study sought to determine whether neural ...

Changes in the gut microbiome may be a tell-tale sign of the onset of rheumatoid arthritis. Image credit: Instants/Getty Images. “There is still a lot we don’t understand about rheumatoid arthritis ...

SAN DIEGO, June 03, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that ...